Association Between CYP450 Polymorphisms and Treatment Outcomes of Escitalopram and Venlafaxine in Patients with Post Stroke Depression

Yanyan Wang, Wenzhe Sun, Chensheng Pan, Zhou Zhu, Guo Li, Xin Zhao, Suiqiang Zhu

Open source

DOI
10.2147/ndt.s610626
Published
2026-09
Container
Neuropsychiatric Disease and Treatment
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ndt.s610626,
  title = {Association Between CYP450 Polymorphisms and Treatment Outcomes of Escitalopram and Venlafaxine in Patients with Post Stroke Depression},
  author = {Yanyan Wang and Wenzhe Sun and Chensheng Pan and Zhou Zhu and Guo Li and Xin Zhao and Suiqiang Zhu},
  year = {2026},
  journal = {Neuropsychiatric Disease and Treatment},
  doi = {10.2147/ndt.s610626},
  url = {https://doi.org/10.2147/ndt.s610626}
}

RIS

TY  - JOUR
TI  - Association Between CYP450 Polymorphisms and Treatment Outcomes of Escitalopram and Venlafaxine in Patients with Post Stroke Depression
AU  - Yanyan Wang
AU  - Wenzhe Sun
AU  - Chensheng Pan
AU  - Zhou Zhu
AU  - Guo Li
AU  - Xin Zhao
AU  - Suiqiang Zhu
PY  - 2026
JO  - Neuropsychiatric Disease and Treatment
DO  - 10.2147/ndt.s610626
UR  - https://doi.org/10.2147/ndt.s610626
ER  - 

APA

Wang, Y., Sun, W., Pan, C., Zhu, Z., Li, G., Zhao, X., & Zhu, S. (2026). Association Between CYP450 Polymorphisms and Treatment Outcomes of Escitalopram and Venlafaxine in Patients with Post Stroke Depression. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/ndt.s610626

Source records